FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Nitric Oxide topics
Nitric Oxide
Cerebral Ischemia
Nasal Cavity
Vascular Disease
Peripheral Vascular Disease
Theophylline
Circulation
Medical Device
Prophylaxis
Antimicrobial
Amino Acid
Bacterial Infection
Wound Healing
Bone Healing
Neuropathy

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Nitric Oxide patents



      
           
This page is updated frequently with new Nitric Oxide-related patent applications. Subscribe to the Nitric Oxide RSS feed to automatically get the update: related Nitric RSS feeds. RSS updates for this page: Nitric Oxide RSS RSS


Measuring nitric oxide in fluid

Methods and apparatus for measuring nitric oxide in fluid

Date/App# patent app List of recent Nitric Oxide-related patents
07/17/14
20140200265
 Usage of 1,3,5,7-tetrahydroxy-8-isoprenylxanthone for treating inflammation patent thumbnailUsage of 1,3,5,7-tetrahydroxy-8-isoprenylxanthone for treating inflammation
This invention relates to the use of a natural compound from natural sources for its therapeutic uses. More particularly, it relates to a compound 1,3,5,7-tetrahydroxy-8-isoprenylxanthone (ti, fig.
07/17/14
20140200219
 Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases patent thumbnailMethods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
The present methods and compositions are of use for treatment of conditions involving fibrosis, such as peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a pde-4 inhibitor, a pde-5 inhibitor, a compound that elevates cgmp and/or pkg, a stimulator of guanylyl cyclase and/or pkg, a combination of a compound that elevates cgmp, pkg or no with an antioxidant that decreases ros, or a compound that increases mmp activity..
07/17/14
20140197044
 Measuring nitric oxide in fluid patent thumbnailMeasuring nitric oxide in fluid
Apparatus and methods in accordance with one or more preferred embodiments of the present invention are used to measure nitric oxide in a fluid, and each includes a sample injection port; a pump; a measurement chamber; an electromagnetic radiation source; one or controls and user interfaces; and a cartridge. The cartridge includes a sample chamber; an electromagnetic radiation and heat chamber; and a gas permeable membrane.
07/17/14
20140197043
 Methods and apparatus for measuring nitric oxide in fluid patent thumbnailMethods and apparatus for measuring nitric oxide in fluid
An exemplary apparatus for measuring nitric oxide in a fluid includes a sample injection port; a pump and reservoir; a valve; a measurement chamber; an electromagnetic radiation source; controls and user interface; and a cartridge. The cartridge includes a sample chamber a mix chamber; a sample degassing chamber; and a planar reaction chamber.
07/10/14
20140194808
 Methods and systems for use of photolyzable nitric oxide donors patent thumbnailMethods and systems for use of photolyzable nitric oxide donors
The present disclosure relates to methods and systems for use of photolyzable nitric oxide donors for the treatment of sexual dysfunction.. .
07/03/14
20140187481
 Transdermal pharmaceutical delivery composition patent thumbnailTransdermal pharmaceutical delivery composition
A pharmaceutically delivery system is described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide at the skin surface. The dosage form may be in any pharmaceutically acceptable carrier means and comprises an acidifying agent adapted to reduce the ph at the environment.
07/03/14
20140186211
 Rapid surface disinfection method and apparatus patent thumbnailRapid surface disinfection method and apparatus
A device for rapidly sanitizing a surface is described. The device has an enclosure having an opening adapted to insert a surface, and an interior; a liquid nitric oxide solution applicator; and an absorbent material.
06/26/14
20140180085
 Renal injury inhibiting devices, systems, and methods employing low-frequency ultrasound or other cyclical pressure energies patent thumbnailRenal injury inhibiting devices, systems, and methods employing low-frequency ultrasound or other cyclical pressure energies
Improved devices, systems, and methods treatment of patients can be used to help mitigate injury to the kidneys by applying cyclical mechanical pressure energy at low intensities. The energy often be selectively directed from non-invasive transducers disposed outside the patients.
06/26/14
20140179014
 Fluorescent nitric oxide probes and associated methods patent thumbnailFluorescent nitric oxide probes and associated methods
Nitric oxide probes including a compound represented by formula, i, ii, iii, iv, v, vi or a combination thereof are provided. Methods of using these nitric oxide probes to detect nitric oxide are also provided..
06/26/14
20140178504
 Modular biocompatible materials for medical devices and uses thereof patent thumbnailModular biocompatible materials for medical devices and uses thereof
The present disclosure is directed to a method of producing nitric oxide comprising (i) providing a composition comprising a metal-organic framework, and (ii) exposing the composition to a nitric oxide-releasing compound. The disclosure also is directed to compositions, coatings, and medical devices comprising a metal-organic framework..
06/19/14
20140171395
Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures
Provided here are nitric oxide-releasing compounds that include at least two different no donor functional groups of the same class. In some embodiments, such nitric oxide-releasing compounds are macromolecules such as dendrimer and co-condensed silica.
06/19/14
20140170073
Nanoparticulate probe for in vivo monitoring of tissue oxygenation
A new class of micro- and nano-particulate paramagnetic spin probes especially useful for magnetic resonance imaging techniques, including electron paramagnetic resonance (epr) and magnetic resonance imaging (mri). The probes are lithium phthalocyanine derivative compounds.
06/19/14
20140166009
Cannula for minimizing dilution of dosing during nitric oxide delivery
Described are nasal cannulas that improve the precision of the delivered dose for nitric oxide therapy by reducing the dilution of nitric oxide. The nasal cannulas may reduce the total volume and potential for retrograde flow during nitric oxide therapy through the design of the specific dimensions of the flow path and/or having check valves in the nitric oxide delivery line and/or having a flapper or umbrella valve dedicated to nitric oxide delivery.
06/12/14
20140163016
Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
The present invention features benzoxazines, benzothiazines, and related compounds that inhibit nitric oxide synthase (nos), particularly those that selectively inhibit neuronal nitric oxide synthase (nnos) in preference to other nos isoforms. The nos inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions..
06/12/14
20140161718
Synthesis of cu/sapo-34 with variable copper loadings
A cu-amine complex of hydrated copper sulfate and ethylene diamine or an oligomer of ethylene diamine is employed in a direct (one-pot) synthesis of a copper-cation containing silicoaluminophosphate (sapo) zeolite material having the cu/sapo-34 structure. The copper-amine complex is included in an aqueous gel of precursors of the sio2, al2o3, and p2o5 constituents, which are mixed, aged, and thermally treated to form the desired cu/sapo-34 structure.
06/12/14
20140158121
Cannula for minimizing dilution of dosing during nitric oxide delivery
The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (no). As described herein, no dilution can occur because of various factors.
06/05/14
20140154300
Methods and compositions for treatment of lesioned sites of body vessels
Methods and compositions for inducing apoptosis of cells, such as macrophages, at a lesioned site of a body vessel are disclosed herein. Nitric oxide can be directly or indirectly delivered to a treatment site to increase macrophage apoptosis.
06/05/14
20140150789
Cannula for minimizing dilution of dosing during nitric oxide delivery
The present invention generally relates to, amongst other things, systems, devices, materials, and methods that can improve the accuracy and/or precision of nitric oxide therapy by, for example, reducing the dilution of inhaled nitric oxide (no). As described herein, no dilution can occur because of various factors.
05/29/14
20140148438
Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
There is provided compositions and methods for the treatment of respiratory conditions such as pulmonary hypertension and sickle-cell disease in a patient in need thereof. The composition and method are for treating a patient in need thereof by inhalation of a composition containing amino acid ester compounds comprising at least one nitric oxide releasing group and pharmaceutical salts thereof..
05/29/14
20140147920
Specific nnos inhibitors for the therapy and prevention of human melanoma
Methods for melanoma treatment and prevention with selective nitric oxide synthase inhibitor compounds and related pharmaceutical compositions, alone or in conjunction with one or more other melanoma therapies.. .
05/29/14
20140144444
Systems for generating nitric oxide
Various systems generating nitric oxide are disclosed herein. According to one embodiment, the system includes a first gas source providing nitrogen dioxide mixed in air or oxygen, and a second gas source supplying compressed air and/or compressed oxygen.
05/29/14
20140144441
Dosimetric therapeutic gas delivery method for rapid dosimetry adjustment and optimization
The disclosure describes a technique for monitoring patient utilization of inhaled nitric oxide as well as waste exhaust of nitric oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled nitric oxide.
05/29/14
20140144440
Dosimetric therapeutic gas delivery method with feed back control for rapid dosimetry adjustment and optimization
The disclosure describes a technique for monitoring patient utilization of inhaled nitric oxide as well as waste exhaust of nitric oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled nitric oxide.
05/29/14
20140144439
Dosimetric therapeutic gas delivery system for rapid dose monitoring and control
The disclosure describes a technique for monitoring patient utilization of inhaled nitric oxide as well as waste exhaust of nitric oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled nitric oxide.
05/29/14
20140144436
Nitric oxide delivery system
An ambulatory or stationary device for delivery of a therapeutic amount of nitric oxide to an individual's lungs.. .
05/29/14
20140144434
Dosimetric therapeutic gas delivery method for nitric oxide utilization monitoring and control
The disclosure describes a technique for monitoring patient utilization of inhaled nitric oxide as well as waste exhaust of nitric oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled nitric oxide.
05/29/14
20140144433
Dosimetric therapeutic gas delivery system for nitric oxide utilization monitoring and control
The disclosure describes a technique for monitoring patient utilization of inhaled nitric oxide as well as waste exhaust of nitric oxide in gases exhaled from patient lungs. By monitoring the real dose provided to a patient, actual compliance with therapeutic target doses may be monitored to improve patient safety and therapeutic benefit from inhaled nitric oxide.
05/22/14
20140141098
Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle.
05/15/14
20140135396
Treatment of acetaminophen-induced liver damage by the administration of modulators of nitric oxide
The invention is directed to the treatment of patients at risk for liver damage due to the overingestion of acetaminophen by administering agents that increase hepatic levels of nitric oxide.. .
05/15/14
20140135389
Quinone based nitric oxide donating compounds
The present invention relates to nitric oxide donor compounds having a quinone based structure, to processes for their preparation and to their use in the treatment of pathological conditions where a deficit of no plays an important role in their pathogenesis.. .
05/15/14
20140134321
Nitric oxide-releasing coatings
Provided according to embodiments of the invention are no-releasing sol-gel coating formed from a sol precursor solution comprising a backbone alkoxysilane and a diazeniumdiolate-modified alkoxysilane. Further provided are methods of producing no-releasing sol-gel coatings.
05/08/14
20140128784
Isometric system, method and apparatus for isometric exercise
System, method and apparatus for carrying out isometric exercises for therapeutic purposes. As employed in a therapeutic mode the apparatus may only be programmed within mandated therapeutic parameter limitations.
05/08/14
20140128783
Isometric system, method and apparatus for isometric exercise
System, method and apparatus for carrying out isometric exercises for therapeutic purposes. As employed in a therapeutic mode the apparatus may only be programmed within mandated therapeutic parameter limitations.
05/08/14
20140128223
Isometric system, method and apparatus for isometric exercise
System, method and apparatus for carrying out isometric exercises for therapeutic purposes. As employed in a therapeutic mode the apparatus may only be programmed within mandated therapeutic parameter limitations.
05/08/14
20140127330
Method of mixing gases including nitric oxide
A method of delivering nitric oxide can include mixing a first gas including oxygen and a second gas including a nitric oxide-releasing agent within a receptacle to form a gas mixture, where the receptacle includes an inlet, an outlet and a reducing agent, contacting the nitric oxide-releasing agent in the gas mixture with the reducing agent to generate nitric oxide, and delivering the gas mixture including nitric oxide from the receptacle to a mammal.. .
05/08/14
20140127081
Dual platform system for the delivery of nitric oxide
A system for the delivery of nitric oxide can include a first platform including a first source of nitric oxide, a second platform including a second source of a nitric oxide, a delivery line coupled to the first platform and the second platform, and a controller configured to operate the first platform and the second platform simultaneously. A method of delivering nitric oxide can include communicating a first gas including nitric oxide through a first platform to a delivery line, communicating a second gas including nitric oxide through a second platform to the delivery line, and delivering the first gas and the second gas to a mammal via a delivery line..
05/01/14
20140123342
Regulation of stomatal apertures by apyrases and extracellular nucleotides
The role of extracellular nucleotides and apyrase enzymes in the guard cells that border stomata in regulating stomatal aperture and the plant's resistance to drought and pathogens is disclosed herein. Expression of apyrases apy1 and apy2, in guard cell protoplasts is strongly correlated with cell growth, cell secretory activity and with conditions that favor stomatal opening.
05/01/14
20140120574
Fluorescent nitric oxide probes and associated methods
Nitric oxide probes comprising a compound represented by formula i are provided. Methods of using this nitric oxide probes to detect nitric oxide are also provided..
04/24/14
20140113962
Inhibitors of nitric oxide synthase
The current invention discloses novel methods for the inhibition of inducible nitric oxide synthesis (inos) and the production of no. Methods of inhibiting the induction of proinflammatory cytokines are also described.
04/17/14
20140105963
Topical nitric oxide systems and methods of use thereof
The present invention generally relates to compositions and methods for transdermal drug delivery. The compositions can be used in a variety of applications, including treating erectile dysfunction or sexual dysfunction, treating wounds, or causing or promoting hair growth.
04/17/14
20140102448
Conversion of nitrogen dioxide (no2) to nitric oxide (no)
Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid..
04/17/14
20140102447
Systems and devices for generating nitric oxide
Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body.
04/17/14
20140102446
Conversion of nitrogen dioxide (no2) to nitric oxide (no)
Various systems, devices, no2 absorbents, no2 scavengers and no2 recuperator for generating nitric oxide are disclosed herein. According to one embodiment, an apparatus for converting nitrogen dioxide to nitric oxide can include a receptacle including an inlet, an outlet, a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material and the absorbent such that nitrogen dioxide in the gas flow is converted to nitric oxide..
04/10/14
20140100286
Composition for preventing or treating inflammatory diseases comprising veratric acid as effective component
There is provided a composition including a veratric acid for preventing or treating inflammatory diseases. The veratric acid of the present invention has an excellent effect of inhibiting production of nitric oxide, an excellent activity of inhibiting production of il-1β as a pro-inflammatory cytokine, and an excellent effect of inhibiting phosphorylation of mapk, nf-κb, gsk-3β, and c-raf in a macrophage cell stimulated by a stimulation factor that causes an inflammatory reaction.
04/03/14
20140093588
Combinations of nitric oxide and sulfide and methods of use and manufacture thereof
The present invention provides methods of reducing the cytotoxic effects of nitric oxide and sulfides comprising coadministering nitric oxide with sulfide. In addition, the present invention provides novel pharmaceutical compositions comprising both nitric oxide and sulfide.
03/27/14
20140088490
Methods of treatment with nitric oxide at pressures greater than one atmosphere
The present invention provides methods of treatment by delivering nitric oxide at a pressure greater than 1 atmosphere (atm) to a subject in need thereof. Thus, the present invention provides an improved method of treating the skin surface of a subject, and below the skin surface of a subject..
03/27/14
20140088034
Nitric oxide/cgmp pathway inhibition of vla-4 related cell adhesion
The invention provides methods of treating nitric oxide/cgmp pathway-cell adhesion disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits. In one embodiment, the invention relates to a method for down-regulating α4β1-integrin affinity and inhibiting and reversing adhesion formation in patients or subjects in need using a nitric oxide donor..
03/27/14
20140086980
Treatment of erectile dysfunction and other indications
The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use of a hostile biophysical environment.
03/20/14
20140079768
Compositions and methods for treatment of osteoporosis and other indications
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of osteoporosis or other conditions. In some cases, the composition may include nitric oxide.
03/20/14
20140079767
Cancer treatments and compositions for use thereof
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of cancer or other conditions. In some cases, the composition may include nitric oxide.
03/20/14
20140079766
Methods and compositions for muscular and neuromuscular diseases
The present invention generally relates to compositions and methods for treatment of subjects in need of muscle growth or repair. In some cases, the composition may include nitric oxide.
03/20/14
20140079765
Techniques and systems for treatment of neuropathic pain and other indications
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of neuropathic pain or other conditions. In some cases, the composition may include nitric oxide.
03/20/14
20140079764
Treatment and prevention of learning and memory disorders
The present invention generally relates to compositions and methods for transdermal drug delivery, including treatment and prevention of learning and memory disorders, and enhancement of learning or memory. In some cases, the composition may include nitric oxide.
03/20/14
20140079763
Methods and systems for treatment of inflammatory diseases with nitric oxide
The present invention generally relates to compositions and methods for treatment of various inflammatory diseases, such as inflammatory dermatoses and other conditions, e.g., using nitric oxide. Examples of such dermatoses include psoriasis, atopic dermatitis, and contact dermatitis.
03/20/14
20140079762
Treatment of skin and soft tissue infection with nitric oxide
The present invention generally relates to compositions and methods for treatment of skin and/or other soft tissues that are infected with bacteria such as staphylococcus aureus, and/or other infectious organisms. In some cases, the composition may include nitric oxide.
03/20/14
20140079761
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of acne or other conditions. In some cases, the composition may include nitric oxide.
03/20/14
20140079729
Method for improving endothelial function and decreasing cardiovascular morbidity using shilajit
Shilajit in a standardized composition produces a significant improvement in several cardiovascular parameters including ri, aix and sevr. Further, significant reductions in malondialdehyde and increases in nitric oxide levels are provided suggesting improvement in endothelial function.
03/20/14
20140079679
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
The present invention generally relates to compositions and methods for treatment of subjects having or at risk of arteriosclerosis, hypertension, sickle-cell anemia, or other conditions. In some cases, the composition may include nitric oxide.
03/13/14
20140073697
Delivery of ibuprofen and other compounds
The present invention generally relates to the transdermal delivery of various compositions. In some aspects, the transdermal delivery may be facilitated by the use of a hostile biophysical environment.
03/06/14
20140066635
Thiophene-2-carboximidamide based selective neuronal nitric oxide inhibitors
Selective neuronal nitric oxide synthase (nnos) inhibitor compounds designed with one or more thiophene-2-carboximidamide substituents for improved bioavailability.. .
03/06/14
20140066452
Transdermal delivery of beneficial substances effected by a hostile biophysical environment
The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical environment. In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed.
03/06/14
20140065606
Compositions, apparatus and methods for monitoring biomarkers
A single device to collect, transfer, and measure salivary nitric oxide analyte and metabolite, nitrite, a biomarker for nitric oxide, as well as, a method to assess the effects of diet and exercise on changing an individual's nitric oxide status and health.. .
03/06/14
20140065301
Methods of forming rutile titanium dioxide
Methods of forming rutile titanium dioxide comprise exposing a transition metal (such as v, cr, w, mn, ru, os, rh, ir, pt, ge, sn, or pb) to an atmosphere consisting of oxygen gas (o2) to produce an oxidized transition metal over an unoxidized portion of the transition metal. Rutile titanium dioxide is formed over the oxidized transition metal by atomic layer deposition.
03/06/14
20140065200
Nitric oxide-releasing nanorods and their methods of use
In one aspect, the subject matter disclosed herein is directed to no-releasing functionalized nanorods having a desirable aspect ratio. The nanorods are also capable of releasing a desirable amount of no (nitric oxide).


Popular terms: [SEARCH]

Nitric Oxide topics: Nitric Oxide, Cerebral Ischemia, Nasal Cavity, Vascular Disease, Peripheral Vascular Disease, Theophylline, Circulation, Medical Device, Prophylaxis, Antimicrobial, Amino Acid, Bacterial Infection, Wound Healing, Bone Healing, Neuropathy

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Nitric Oxide for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Nitric Oxide with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4741

3502

0 - 1 - 72